Hiporfin photodynamic therapy for early-stage cervical cancer: A case report

IF 3.1 3区医学 Q2 ONCOLOGY

Photodiagnosis and Photodynamic Therapy Pub Date : 2024-12-01 DOI:10.1016/j.pdpdt.2024.104422

Yu Liu , Ruifang Wu , Changzhong Li , Mingmei Li , Hao Li , Lihui Wei , Ruizhen Li

引用次数: 0

Abstract

A 28-year-old female patient, diagnosed with stage IA1 cervical cancer, received PDT treatment with intravenous injection of Hiporfin, a HpD type photosensitizer. The patient's human papillomavirus (HPV) and cytology testing results were negative at the 3-month. At 6 months, the lesions on the cervical surface and within the cervical canal had completely resolved. There were no signs of recurrence or HPV infection during the 12-month follow-up period. There were no serious adverse events reported during or after the PDT treatment.

查看原文本刊更多论文

Hiporfin光动力疗法治疗早期宫颈癌：病例报告

一名 28 岁的女性患者被诊断出患有 IA1 期宫颈癌，接受了静脉注射 HpD 型光敏剂 Hiporfin 的光动力疗法治疗。3 个月时，患者的人类乳头瘤病毒（HPV）和细胞学检测结果均为阴性。6 个月时，宫颈表面和宫颈管内的病变已完全消退。在 12 个月的随访期间，没有出现复发或感染 HPV 的迹象。在 PDT 治疗期间或之后，均未出现严重的不良反应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Photodiagnosis and Photodynamic Therapy ONCOLOGY-

CiteScore

5.80

自引率

24.20%

发文量

509

审稿时长

50 days

期刊介绍： Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.